 | • レポートコード：D0804-16121 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、多発性骨髄腫治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。多発性骨髄腫治療の種類別市場規模（標的療法、化学療法、放射線療法、骨髄移植、その他）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Novartis AG、GlaxoSmithKline plc、Celgene、Amgen Inc.、Johnson & Johnson、Innate Pharma SA、AbbVie Inc.、F. Hoffmann-La Roche Ltd、Millennium Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・多発性骨髄腫治療の北米市場（アメリカ、カナダ、メキシコ） ・多発性骨髄腫治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・多発性骨髄腫治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・多発性骨髄腫治療の南米市場（ブラジル、アルゼンチン） ・多発性骨髄腫治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：標的療法、化学療法、放射線療法、骨髄移植、その他 ・用途別分析：病院、クリニック ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Multiple Myeloma Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Multiple Myeloma Therapy sales will be xx in 2020 from Multiple Myeloma Therapy million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Multiple Myeloma Therapy market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Multiple Myeloma Therapy industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Multiple Myeloma Therapy and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Multiple Myeloma Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Multiple Myeloma Therapy market has been segmented into:
Targeted Therapy
Chemotherapy
Radiotherapy
Bone Marrow Transplant
Others
By Application, Multiple Myeloma Therapy has been segmented into:
Hospital
Clinic
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Multiple Myeloma Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Multiple Myeloma Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Multiple Myeloma Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Multiple Myeloma Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Multiple Myeloma Therapy Market Share Analysis
Multiple Myeloma Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Multiple Myeloma Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Multiple Myeloma Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Multiple Myeloma Therapy are:
Sanofi
Novartis AG
GlaxoSmithKline plc
Celgene
Amgen Inc.
Johnson & Johnson
Innate Pharma SA
AbbVie Inc.
F. Hoffmann-La Roche Ltd
Millennium Pharmaceuticals
Among other players domestic and global, Multiple Myeloma Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Multiple Myeloma Therapy Market Overview
1.1 Product Overview and Scope of Multiple Myeloma Therapy
1.2 Classification of Multiple Myeloma Therapy by Type
1.2.1 Global Multiple Myeloma Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Multiple Myeloma Therapy Revenue Market Share by Type in 2019
1.2.3 Targeted Therapy
1.2.4 Chemotherapy
1.2.5 Radiotherapy
1.2.6 Bone Marrow Transplant
1.2.7 Others
1.3 Global Multiple Myeloma Therapy Market by Application
1.3.1 Overview: Global Multiple Myeloma Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Multiple Myeloma Therapy Market by Regions
1.4.1 Global Multiple Myeloma Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Multiple Myeloma Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Multiple Myeloma Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Multiple Myeloma Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Multiple Myeloma Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Multiple Myeloma Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Multiple Myeloma Therapy Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Multiple Myeloma Therapy Industry Impact
1.5.1 COVID-19 Potential Implications for the Multiple Myeloma Therapy
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Multiple Myeloma Therapy
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Multiple Myeloma Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis AG SWOT Analysis
2.2.4 Novartis AG Product and Services
2.2.5 Novartis AG Multiple Myeloma Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline plc
2.3.1 GlaxoSmithKline plc Details
2.3.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline plc SWOT Analysis
2.3.4 GlaxoSmithKline plc Product and Services
2.3.5 GlaxoSmithKline plc Multiple Myeloma Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Celgene
2.4.1 Celgene Details
2.4.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Celgene SWOT Analysis
2.4.4 Celgene Product and Services
2.4.5 Celgene Multiple Myeloma Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Amgen Inc.
2.5.1 Amgen Inc. Details
2.5.2 Amgen Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Amgen Inc. SWOT Analysis
2.5.4 Amgen Inc. Product and Services
2.5.5 Amgen Inc. Multiple Myeloma Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson Product and Services
2.6.4 Johnson & Johnson Multiple Myeloma Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Innate Pharma SA
2.7.1 Innate Pharma SA Details
2.7.2 Innate Pharma SA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Innate Pharma SA Product and Services
2.7.4 Innate Pharma SA Multiple Myeloma Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 AbbVie Inc.
2.8.1 AbbVie Inc. Details
2.8.2 AbbVie Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AbbVie Inc. Product and Services
2.8.4 AbbVie Inc. Multiple Myeloma Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 F. Hoffmann-La Roche Ltd
2.9.1 F. Hoffmann-La Roche Ltd Details
2.9.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 F. Hoffmann-La Roche Ltd Product and Services
2.9.4 F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Millennium Pharmaceuticals
2.10.1 Millennium Pharmaceuticals Details
2.10.2 Millennium Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Millennium Pharmaceuticals Product and Services
2.10.4 Millennium Pharmaceuticals Multiple Myeloma Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Multiple Myeloma Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Multiple Myeloma Therapy Players Market Share
3.2.2 Top 10 Multiple Myeloma Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Multiple Myeloma Therapy Revenue and Market Share by Regions
4.2 North America Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
5 North America Multiple Myeloma Therapy Revenue by Countries
5.1 North America Multiple Myeloma Therapy Revenue by Countries (2015-2020)
5.2 USA Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
6 Europe Multiple Myeloma Therapy Revenue by Countries
6.1 Europe Multiple Myeloma Therapy Revenue by Countries (2015-2020)
6.2 Germany Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
6.4 France Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Multiple Myeloma Therapy Revenue by Countries
7.1 Asia-Pacific Multiple Myeloma Therapy Revenue by Countries (2015-2020)
7.2 China Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
7.5 India Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
8 South America Multiple Myeloma Therapy Revenue by Countries
8.1 South America Multiple Myeloma Therapy Revenue by Countries (2015-2020)
8.2 Brazil Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Multiple Myeloma Therapy by Countries
9.1 Middle East & Africa Multiple Myeloma Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Multiple Myeloma Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Multiple Myeloma Therapy Market Forecast by Type (2019-2024)
10.3 Targeted Therapy Revenue Growth Rate (2015-2025)
10.4 Chemotherapy Revenue Growth Rate (2015-2025)
10.5 Radiotherapy Revenue Growth Rate (2015-2025)
10.6 Bone Marrow Transplant Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Multiple Myeloma Therapy Market Segment by Application
11.1 Global Multiple Myeloma Therapy Revenue Market Share by Application (2015-2020)
11.2 Multiple Myeloma Therapy Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
12 Global Multiple Myeloma Therapy Market Size Forecast (2021-2025)
12.1 Global Multiple Myeloma Therapy Market Size Forecast (2021-2025)
12.2 Global Multiple Myeloma Therapy Market Forecast by Regions (2021-2025)
12.3 North America Multiple Myeloma Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Multiple Myeloma Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Multiple Myeloma Therapy Revenue Market Forecast (2021-2025)
12.6 South America Multiple Myeloma Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Multiple Myeloma Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Multiple Myeloma Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Multiple Myeloma Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Multiple Myeloma Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Multiple Myeloma Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Multiple Myeloma Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Sanofi Corporate Information, Location and Competitors
Table 7. Sanofi Multiple Myeloma Therapy Major Business
Table 8. Sanofi Multiple Myeloma Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Sanofi SWOT Analysis
Table 10. Sanofi Multiple Myeloma Therapy Product and Solutions
Table 11. Sanofi Multiple Myeloma Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Novartis AG Corporate Information, Location and Competitors
Table 13. Novartis AG Multiple Myeloma Therapy Major Business
Table 14. Novartis AG Multiple Myeloma Therapy Total Revenue (USD Million) (2018-2019)
Table 15. Novartis AG SWOT Analysis
Table 16. Novartis AG Multiple Myeloma Therapy Product and Solutions
Table 17. Novartis AG Multiple Myeloma Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. GlaxoSmithKline plc Corporate Information, Location and Competitors
Table 19. GlaxoSmithKline plc Multiple Myeloma Therapy Major Business
Table 20. GlaxoSmithKline plc Multiple Myeloma Therapy Total Revenue (USD Million) (2017-2018)
Table 21. GlaxoSmithKline plc SWOT Analysis
Table 22. GlaxoSmithKline plc Multiple Myeloma Therapy Product and Solutions
Table 23. GlaxoSmithKline plc Multiple Myeloma Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Celgene Corporate Information, Location and Competitors
Table 25. Celgene Multiple Myeloma Therapy Major Business
Table 26. Celgene Multiple Myeloma Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Celgene SWOT Analysis
Table 28. Celgene Multiple Myeloma Therapy Product and Solutions
Table 29. Celgene Multiple Myeloma Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Amgen Inc. Corporate Information, Location and Competitors
Table 31. Amgen Inc. Multiple Myeloma Therapy Major Business
Table 32. Amgen Inc. Multiple Myeloma Therapy Total Revenue (USD Million) (2017-2018)
Table 33. Amgen Inc. SWOT Analysis
Table 34. Amgen Inc. Multiple Myeloma Therapy Product and Solutions
Table 35. Amgen Inc. Multiple Myeloma Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Johnson & Johnson Corporate Information, Location and Competitors
Table 37. Johnson & Johnson Multiple Myeloma Therapy Major Business
Table 38. Johnson & Johnson Multiple Myeloma Therapy Total Revenue (USD Million) (2017-2018)
Table 39. Johnson & Johnson SWOT Analysis
Table 40. Johnson & Johnson Multiple Myeloma Therapy Product and Solutions
Table 41. Johnson & Johnson Multiple Myeloma Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Innate Pharma SA Corporate Information, Location and Competitors
Table 43. Innate Pharma SA Multiple Myeloma Therapy Major Business
Table 44. Innate Pharma SA Multiple Myeloma Therapy Total Revenue (USD Million) (2017-2018)
Table 45. Innate Pharma SA SWOT Analysis
Table 46. Innate Pharma SA Multiple Myeloma Therapy Product and Solutions
Table 47. Innate Pharma SA Multiple Myeloma Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. AbbVie Inc. Corporate Information, Location and Competitors
Table 49. AbbVie Inc. Multiple Myeloma Therapy Major Business
Table 50. AbbVie Inc. Multiple Myeloma Therapy Total Revenue (USD Million) (2017-2018)
Table 51. AbbVie Inc. SWOT Analysis
Table 52. AbbVie Inc. Multiple Myeloma Therapy Product and Solutions
Table 53. AbbVie Inc. Multiple Myeloma Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. F. Hoffmann-La Roche Ltd Corporate Information, Location and Competitors
Table 55. F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Major Business
Table 56. F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Total Revenue (USD Million) (2017-2018)
Table 57. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 58. F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Product and Solutions
Table 59. F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Millennium Pharmaceuticals Corporate Information, Location and Competitors
Table 61. Millennium Pharmaceuticals Multiple Myeloma Therapy Major Business
Table 62. Millennium Pharmaceuticals Multiple Myeloma Therapy Total Revenue (USD Million) (2017-2018)
Table 63. Millennium Pharmaceuticals SWOT Analysis
Table 64. Millennium Pharmaceuticals Multiple Myeloma Therapy Product and Solutions
Table 65. Millennium Pharmaceuticals Multiple Myeloma Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Multiple Myeloma Therapy Revenue (Million USD) by Players (2015-2020)
Table 67. Global Multiple Myeloma Therapy Revenue Share by Players (2015-2020)
Table 68. Global Multiple Myeloma Therapy Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Multiple Myeloma Therapy Revenue Market Share by Regions (2015-2020)
Table 70. North America Multiple Myeloma Therapy Revenue by Countries (2015-2020)
Table 71. North America Multiple Myeloma Therapy Revenue Market Share by Countries (2015-2020)
Table 72. Europe Multiple Myeloma Therapy Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Multiple Myeloma Therapy Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Multiple Myeloma Therapy Revenue by Countries (2015-2020)
Table 75. South America Multiple Myeloma Therapy Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Multiple Myeloma Therapy Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Multiple Myeloma Therapy Revenue Market Share by Countries (2015-2020)
Table 78. Global Multiple Myeloma Therapy Revenue (Million USD) by Type (2015-2020)
Table 79. Global Multiple Myeloma Therapy Revenue Share by Type (2015-2020)
Table 80. Global Multiple Myeloma Therapy Revenue Forecast by Type (2021-2025)
Table 81. Global Multiple Myeloma Therapy Revenue by Application (2015-2020)
Table 82. Global Multiple Myeloma Therapy Revenue Share by Application (2015-2020)
Table 83. Global Multiple Myeloma Therapy Revenue Forecast by Application (2021-2025)
Table 84. Global Multiple Myeloma Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Multiple Myeloma Therapy Picture
Figure 2. Global Multiple Myeloma Therapy Revenue Market Share by Type in 2019
Figure 3. Targeted Therapy Picture
Figure 4. Chemotherapy Picture
Figure 5. Radiotherapy Picture
Figure 6. Bone Marrow Transplant Picture
Figure 7. Others Picture
Figure 8. Multiple Myeloma Therapy Revenue Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Global Multiple Myeloma Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Multiple Myeloma Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Multiple Myeloma Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Multiple Myeloma Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Multiple Myeloma Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Multiple Myeloma Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Multiple Myeloma Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Multiple Myeloma Therapy Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Multiple Myeloma Therapy Revenue Market Share in 2019
Figure 20. Global Top 10 Players Multiple Myeloma Therapy Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Multiple Myeloma Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Multiple Myeloma Therapy Revenue Market Share by Regions (2015-2020)
Figure 24. Global Multiple Myeloma Therapy Revenue Market Share by Regions in 2018
Figure 25. North America Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 26. Europe Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 28. South America Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 30. North America Multiple Myeloma Therapy Revenue Market Share by Countries (2015-2020)
Figure 31. North America Multiple Myeloma Therapy Revenue Market Share by Countries in 2019
Figure 32. USA Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Canada Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 35. Europe Multiple Myeloma Therapy Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Multiple Myeloma Therapy Revenue Market Share by Countries in 2019
Figure 37. Germany Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 38. UK Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 39. France Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Russia Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Italy Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Multiple Myeloma Therapy Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Multiple Myeloma Therapy Revenue Market Share by Countries in 2019
Figure 44. China Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Japan Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Korea Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 47. India Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 49. South America Multiple Myeloma Therapy Revenue Market Share by Countries (2015-2020)
Figure 50. South America Multiple Myeloma Therapy Revenue Market Share by Countries in 2019
Figure 51. Brazil Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Multiple Myeloma Therapy Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Multiple Myeloma Therapy Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 56. UAE Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Multiple Myeloma Therapy Revenue and Growth Rate (2015-2020)
Figure 59. Global Multiple Myeloma Therapy Revenue Share by Type (2015-2020)
Figure 60. Global Multiple Myeloma Therapy Revenue Share by Type in 2019
Figure 61. Global Multiple Myeloma Therapy Market Share Forecast by Type (2021-2025)
Figure 62. Global Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 63. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 64. Global Radiotherapy Revenue Growth Rate (2015-2020)
Figure 65. Global Bone Marrow Transplant Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Multiple Myeloma Therapy Revenue Share by Application (2015-2020)
Figure 68. Global Multiple Myeloma Therapy Revenue Share by Application in 2019
Figure 69. Global Multiple Myeloma Therapy Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospital Revenue Growth Rate (2015-2020)
Figure 71. Global Clinic Revenue Growth Rate (2015-2020)
Figure 72. Global Multiple Myeloma Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Multiple Myeloma Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Multiple Myeloma Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Multiple Myeloma Therapy Revenue Market Forecast (2021-2025)
Figure 76. Europe Multiple Myeloma Therapy Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Multiple Myeloma Therapy Revenue Market Forecast (2021-2025)
Figure 78. South America Multiple Myeloma Therapy Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Multiple Myeloma Therapy Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
多連装ロケットランチャーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Multiple Rocket Launchers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 多段ブースターポンプの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Multiple Stage Booster Pump market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- マルチチャンバープレフィルドシリンジの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Multiple Chamber Prefilled Syringe market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- 使い捨て歯科用ディスペンサーデバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Multiple-Use Dental Dispenser Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Multipl…
- パラフィン理学療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Paraffin Physical Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Paraffin Physical T…